Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TELA Bio, Inc. - Common stock (NQ:TELA)

1.020 -0.050 (-4.67%)
Streaming Delayed Price Updated: 11:12 AM EST, Jan 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TELA Bio, Inc. - Common stock

< Previous 1 2 3 4 5 6 Next >
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
Alphabet To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 13, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
What's going on in today's after hours session ↗
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
These Analysts Cut Their Forecasts On TELA Bio After Q3 Earnings ↗
 
Via Benzinga
News headline image
TELA Bio Inc (NASDAQ:TELA) Reports Mixed Q3 2025 Results, Misses Revenue Estimates ↗
TELA Bio reports Q3 2025 results with 9% revenue growth to $20.7M, missing estimates. The company improved its net loss and secured new financing for future expansion. 
Via Chartmill
News headline image
TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
Uncovering Potential: TELA Bio's Earnings Preview ↗
 
Via Benzinga
News headline image
TELA Bio to Announce Third Quarter 2025 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Appoints William Plovanic to Board of Directors
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
TELA Bio Reports Second Quarter 2025 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For August 11, 2025 ↗
 
Via Benzinga
News headline image
TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio to Announce Second Quarter 2025 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair
Based on market research, inguinal hernia repair is the most common type of hernia repair 
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Appoints Jeffrey Blizard as President
Company Further Strengthens Executive Leadership Team to Drive Next Phase of Growth 
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
News headline image
TELA Bio Reports First Quarter 2025 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.